Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy

Area of Science:

• Bone Biology
• Endocrinology
• Immunology

Background:

• Platelet-activating factor (PAF) is implicated in diseases with bone resorption.
• The specific role of PAF in bone metabolism, particularly in osteoporosis, is not well understood.

Purpose of the Study:

• To investigate the function of PAF in bone metabolism and its role in postmenopausal osteoporosis.
• To determine if PAF links estrogen depletion to increased bone resorption.

Main Methods:

• Utilized PAF receptor-deficient mice to model postmenopausal osteoporosis induced by ovariectomy.
• Assessed bone mineral density and histomorphometric parameters.
• Examined PAF biosynthesis enzymes and receptor expression in osteoclasts and osteoblasts.
• Investigated the effect of PAF receptor stimulation and antagonism on osteoclast survival and activity in vitro and in organ cultures.

Main Results:

• PAF receptor-deficient mice exhibited significantly reduced bone resorption after ovariectomy.
• Osteoclasts, not osteoblasts, expressed higher levels of PAF biosynthesis enzymes and the functional PAF receptor.
• Pro-inflammatory cytokines (TNF-alpha, IL-1beta) enhanced PAF production in osteoclasts.
• PAF receptor stimulation prolonged osteoclast survival and activity; its inhibition reduced osteoclast survival and calcium resorption.

Conclusions:

• Estrogen depletion, via inflammatory cytokines, enhances PAF production, acting as an autocrine factor for osteoclast function.
• PAF plays a critical role in estrogen depletion-induced bone resorption and osteoporosis.
• Targeting PAF offers a potential therapeutic strategy for preventing postmenopausal bone loss without affecting osteoblast function.